Erscheinungsjahr
Medientyp
Format
Lizenz
Sprache
-
White button mushroom (Agaricus bisporus) disrupts androgen receptor signaling in human prostate cancer cells and patient-derived xenograft
Elsevier | 2020|Schlagwörter: enzalutamide -
What do we know about treatment sequencing of abiraterone, enzalutamide, and chemotherapy in metastatic castration-resistant prostate cancer?
Online Contents | 2015|Schlagwörter: Enzalutamide -
Validation of an LC-MS/MS method for simultaneous quantification of abiraterone, enzalutamide and darolutamide in human plasma
Elsevier | 2023|Schlagwörter: Enzalutamide -
Use of record linkage to evaluate treatment outcomes and trial eligibility in a real‐world metastatic prostate cancer population in Scotland
Wiley | 2020|Schlagwörter: enzalutamide -
Uroonkologische und nuklearmedizinische Behandlungsmöglichkeiten beim metastasierten, kastrationsresistenten Prostatakarzinom (mCRPC)
Thieme Verlag | 2019|Schlagwörter: enzalutamide -
Upregulation of PSMA Expression by Enzalutamide in Patients with Advanced mCRPC
Freier ZugriffDataCite | 2022|Schlagwörter: enzalutamide -
Upregulation of PSMA Expression by Enzalutamide in Patients with Advanced mCRPC
Freier ZugriffBASE | 2022|Schlagwörter: enzalutamide -
Upregulation of glucocorticoid receptor‐mediated glucose transporter 4 in enzalutamide‐resistant prostate cancer
Freier ZugriffWiley | 2021|Schlagwörter: enzalutamide -
Unintentional combining enzalutamide with a moderate CYP2C8 inhibitor in a patient with metastatic castration-resistant prostate cancer: a case report
Online Contents | 2022|Schlagwörter: Enzalutamide -
Understanding taxanes in prostate cancer; importance of intratumoral drug accumulation
Wiley | 2016|Schlagwörter: enzalutamide‐resistant prostate cancer -
Tumor Inhibition by Enzalutamide in a Xenograft Model of Ovarian Cancer
Taylor & Francis Verlag | 2016|Schlagwörter: Enzalutamide -
Treatment of non-metastatic castration-resistant prostate cancer: facing age-related comorbidities and drug–drug interactions
Freier ZugriffTaylor & Francis Verlag | 2022|Schlagwörter: enzalutamide -
Treatment of Metastatic, Castration-resistant, Docetaxel-resistant Prostate Cancer: A Systematic Review of Literature With a Network Meta-analysis of Randomized Clinical Trials
Bentham Science Publishers | 2018|Schlagwörter: enzalutamide -
Treatment in hormone-sensitive metastatic prostate cancer: factors to consider when personalizing therapy
Taylor & Francis Verlag | 2020|Schlagwörter: enzalutamide -
TP53 loss‐of‐function causes vulnerability to autophagy inhibition in aggressive prostate cancer
Wiley | 2022|Schlagwörter: Enzalutamide -
Toxicity profile characteristics of novel androgen-deprivation therapy agents in patients with prostate cancer: a meta-analysis
Taylor & Francis Verlag | 2018|Schlagwörter: enzalutamide -
Toxicity, Adverse Events, and Quality of Life Associated with the Treatment of Metastatic Castration-Resistant Prostate Cancer
Karger Verlag | 2017|Schlagwörter: Enzalutamide -
TLE3 loss confers AR inhibitor resistance by facilitating GR-mediated human prostate cancer cell growth
Freier ZugriffDOAJ | 2019|Schlagwörter: Enzalutamide -
Time on treatment with abiraterone and enzalutamide in the Patient-overview Prostate Cancer in The National Prostate Cancer Register of Sweden
Freier ZugriffTaylor & Francis Verlag | 2021|Schlagwörter: enzalutamide -
Third-line treatment and 177Lu-PSMA radioligand therapy of metastatic castration-resistant prostate cancer: a systematic review
Freier ZugriffOnline Contents | 2017|Schlagwörter: Enzalutamide -
The safety and efficacy of enzalutamide in the treatment of advanced prostate cancer
Taylor & Francis Verlag | 2016|Schlagwörter: Enzalutamide -
Therapiemonitoring beim metastasierten kastrationsresistenten Prostatakarzinom
Thieme Verlag | 2017|Schlagwörter: enzalutamide -
Therapiemonitoring beim metastasierten kastrationsresistenten Prostatakarzinom
Thieme Verlag | 2017|Schlagwörter: enzalutamide -
Therapeutic management of bone metastasis in prostate cancer: an update
Taylor & Francis Verlag | 2016|Schlagwörter: enzalutamide -
The presence of lymph node metastases and time to castration resistance predict the therapeutic effect of enzalutamide for castration-resistant prostate cancer
Online Contents | 2022|Schlagwörter: Enzalutamide -
The pluripotency factor Nanog is directly upregulated by the Androgen Receptor in prostate cancer cells
Wiley | 2014|Schlagwörter: enzalutamide -
The influence of treatment sequence in the prognostic value of TMPRSS2‐ERG as biomarker of taxane resistance in castration‐resistant prostate cancer
Wiley | 2019|Schlagwörter: enzalutamide -
The importance of targeting intracrinology in prostate cancer management
Online Contents | 2018|Schlagwörter: Enzalutamide -
The impact of patient characteristics on enzalutamide pharmacokinetics and how this relates to treatment toxicity and efficacy in metastatic prostate cancer patients
Freier ZugriffOnline Contents | 2020|Schlagwörter: Enzalutamide -
The impact of enzalutamide on quality of life in men with metastatic hormone‐sensitive prostate cancer based on prior therapy, risk, and symptom subgroups
Wiley | 2022|Schlagwörter: enzalutamide -
The Epidemiological, Mechanistic and Potential Clinical Role of Androgen Receptor (AR) in Urothelial Carcinoma
Bentham Science Publishers | 2016|Schlagwörter: enzalutamide -
The efficacy and safety of enzalutamide with trastuzumab in patients with HER2+ and androgen receptor-positive metastatic or locally advanced breast cancer
Freier ZugriffOnline Contents | 2021|Schlagwörter: Enzalutamide -
The crosstalk between ubiquitination and endocrine therapy
Online Contents | 2023|Schlagwörter: Enzalutamide -
The Correlation between EGFR and Androgen Receptor Pathways: A Novel Potential Prognostic Marker in Gastric Cancer
Bentham Science Publishers | 2019|Schlagwörter: Enzalutamide (ENZ). -
TGF‐β receptor I inhibitor enhances response to enzalutamide in a pre‐clinical model of advanced prostate cancer
Wiley | 2019|Schlagwörter: enzalutamide -
Taxane chemotherapy vs antiandrogen agents as first‐line therapy for metastatic castration‐resistant prostate cancer
Wiley | 2018|Schlagwörter: enzalutamide -
Targeting tumor and bone microenvironment: Novel therapeutic opportunities for castration-resistant prostate cancer patients with bone metastasis
Elsevier | 2023|Schlagwörter: Enzalutamide -
Targeting the KDM4B–AR–c‐Myc axis promotes sensitivity to androgen receptor‐targeted therapy in advanced prostate cancer
Wiley | 2020|Schlagwörter: enzalutamide resistance -
Targeting the fibroblast growth factor pathway in molecular subtypes of castration‐resistant prostate cancer
Wiley | 2024|Schlagwörter: enzalutamide -
Targeting prostate cancer with compounds possessing dual activity as androgen receptor antagonists and HDAC6 inhibitors
Elsevier | 2016|Schlagwörter: Enzalutamide -
Targeting prostate cancer cells with enzalutamide‐HDAC inhibitor hybrid drug 2‐75
Wiley | 2019|Schlagwörter: enzalutamide -
Targeting non coding RNA regulated Lineage Plasticity to Overcome Antiandrogen Resistance in Advanced Prostate Cancer
NTIS | 2019|Schlagwörter: Enzalutamide resistance -
Targeting DNA Damage Response in Prostate Cancer by Inhibiting Androgen Receptor-CDC6-ATR-Chk1 Signaling
Freier ZugriffDOAJ | 2017|Schlagwörter: enzalutamide -
Targeting Androgen Receptor in Breast Cancer: Enzalutamide as a Novel Breast Cancer Therapeutic
NTIS | 2015Schlagwörter: Enzalutamide -
Targeting Androgen Receptor in Breast Cancer: Enzalutamide as a Novel Breast Cancer Therapeutic
NTIS | 2014|Schlagwörter: ENZALUTAMIDE -
Targeting Androgen Receptor in Breast Cancer: Enzalutamide as a Novel Breast Cancer Therapeutic
NTIS | 2014|Schlagwörter: ENZALUTAMIDE -
Targeting androgen receptor for prostate cancer therapy: From small molecules to PROTACs
Elsevier | 2022|Schlagwörter: Enzalutamide resistant
Meine Suche schicken an (beta)
Schicken Sie ihre Suchanfrage (Suchterm ohne Filter) an andere Datenbanken, Portale und Kataloge, um ggf. weitere interessante Treffer zu finden:
Dimensions ist eine Datenbank für Abstracts und Zitate, die Informationen zu Forschungsförderungen mit daraus resultierenden Veröffentlichungen, Studien und Patenten verknüpft.
Im TIB AV-Portal können audiovisuelle Medien aus Wissenschaft und Lehre recherchiert und eigene wissenschaftliche Videos publiziert werden.
Im FID move kann nach fachspezifischer Literatur, Forschungsdaten und weitere Informationen aus der Mobilitäts- und Verkehrsforschung gesucht werden.
Der Open Research Knowledge Graph liefert strukturiert beschriebene Forschungsinhalte und macht diese vergleichbar.
Frei zugänglicher Ausschnitt der Verbunddatenbank K10plus des GBV und des SWB mit für die Fernleihe und Direktlieferdienste relevanten Materialien.